Anlon Healthcare valuation

Share price at each year-end
Tap a line for its trendCurrentlast closeFY26Mar 2026
Price multiples — at each FY-end close
4.56×—
0.56×—
0.76×—
Enterprise multiples
1.13×—
4.08×—
4.22×—
Yield
21.9%—
−61.1%—
Reference — adjusted share basis
₹24.47—
₹5.36₹5.36
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

AHCL₹24.47

Anlon Healthcare Limited

· Pharma & Health
₹ CrorePeersANUHPHRWANBURYBAJAJHCAREZIMLABTHEMISMEDLINCOLNSIGACHIVALIANTLABMcap ₹130 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY26
31/03/2026
Current
last close
Price Multiples — at each FY-end close
P/E—4.56
P/B—0.56
P/Sales—0.76
Enterprise Multiples
EV/Sales—1.13
EV/EBITDA—4.08
EV/EBIT—4.22
Yield
Earnings Yield %—21.92
FCF Yield %—-61.08
Reference — adjusted share basis
Price (FY-end close, adj.)—24.47
EPS (adj.)5.365.36
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.